[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100446781":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":42,"locations":52,"responsibleParty":70,"collaborators":24,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":76,"sex":82,"minAge":83,"maxAge":24,"enrollmentInfo":84,"targetDuration":24,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":24,"overallStatus":55,"whyStopped":24,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Central Hospital, Nancy, France","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with chronic HFpEF coming for scheduled day hospitalization or consultation","EXPERIMENTAL","* Clinical examination focusing on congestion\n* Cardiac, pulmonary, peritoneal, jugular and renal venous Doppler ultrasounds\n* Blood sample retrieved for biological assessment and biobanking\n* Telephone follow-up",[13,14,15,16,17],"Procedure: Clinical examination centered on congestion","Procedure: Cardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography","Procedure: Blood and urine sample retrieved for biological assessment and biobanking","Other: Telephone follow-up","Behavioral: Kansas City Cardiomyopathy Questionnaire (KCCQ)",[19,25,29,33,37],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","Clinical examination centered on congestion","Clinical examination centered on congestion (including the EVEREST, Ambrosy and ASCEND score) will be performed during day hospitalization or consultation",[9],null,{"type":20,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Cardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography","Cardiac, vena cava, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography will be performed during day hospitalization or consultation\u002F peritoneal, jugular and renal Doppler ultrasounds and liver elastography are optional\u002FCardiac echo is optional for patients included in consultation",[9],{"type":20,"name":30,"description":31,"armGroupLabels":32,"otherNames":24},"Blood and urine sample retrieved for biological assessment and biobanking","Blood sample retrieved for biological assessment and biobanking will be performed during day hospitalization or consultation\u002F Urine analysis is optional for patients included in consultation",[9],{"type":6,"name":34,"description":35,"armGroupLabels":36,"otherNames":24},"Telephone follow-up","Telephone follow-up will be performed 3, 12 and 24",[9],{"type":38,"name":39,"description":40,"armGroupLabels":41,"otherNames":24},"BEHAVIORAL","Kansas City Cardiomyopathy Questionnaire (KCCQ)","Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge",[9],[43,49],{"name":44,"role":45,"phone":46,"phoneExt":47,"email":48},"Nicolas GIRERD, MD, PhD","CONTACT","+ 33 3 83 15 73 22","+ 33 3","n.girerd@chru-nancy.fr",{"name":50,"role":45,"phone":46,"phoneExt":47,"email":51},"Sanae BOUALI","s.bouali@chru-nancy.fr",[53],{"facility":54,"status":55,"city":56,"state":24,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"CHRU de Nancy","RECRUITING","Vandœuvre-lès-Nancy","54500","France","FR",{"type":61,"coordinates":62},"Point",[63,64],6.17114,48.66115,{"lat":64,"lon":63},[67],{"name":44,"role":45,"phone":68,"phoneExt":69,"email":48},"+33383157322","+333",{"type":71,"investigatorFullName":72,"investigatorTitle":73,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Pr. Nicolas GIRERD","Principal Investigator","100446781","chronic-heart-failure-with-preserved-ejection-fraction---congestion-evaluation-100446781",false,"NCT05097898","Chronic Heart Failure With Preserved Ejection Fraction - COngestion eValuation","Évaluation de la Congestion en Ambulatoire Chez Les Patients Atteints d'Insuffisance Cardiaque Chronique à Fraction d'éjection préservée. CHF-COV Preserved (Chronic Heart Failure With Preserved Ejection Fraction - COngestion eValuation)","CHF-COV-P","Inclusion Criteria:\n\n* Patients with chronic acute heart failure with preserved ejection fraction admitted in hospital for scheduled day hospitalization or consultation\n* Patient with preserved left ventricular ejection fraction (≥50%).\n* Age ≥18 years\n* Patients having received complete information regarding the study design and having signed their informed consent form.\n* Patient affiliated to or beneficiary of a social security scheme\n\nExclusion Criteria:\n\n* Comorbidity for which the life expectancy is ≤ 3 months\n* Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate \\\u003C15 ml\u002Fmin\u002Fm2 at inclusion.\n* History of lobectomy or pneumonectomy lung surgery\n* Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.\n* Pregnant woman, parturient or nursing mother\n* Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)\n* Adult person who is unable to give consent\n* Person deprived of liberty by a judicial or administrative decision,\n* Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code.","ALL","18 Years",{"count":85,"type":86},200,"ESTIMATED","INTERVENTIONAL",[89],"NA","Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of hospitalization for HF. Furthermore, congestive signs identified in asymptomatic patients are associated with the risk of developing symptomatic HF. The literature supports a multi-modality \u002F integrative evaluation of congestion, combining clinical examination, laboratory results and ultrasound evaluation.\n\nThe main objective of the CHF-COV Preserved study is to identify congestion markers (clinical, biological and ultrasound) quantified during a consultation or day hospitalization for the monitoring of chronic HF with preserved left ventricular ejection fraction that are associated with the risk of all-cause death, hospitalization for acute HF or IV diuretics injection in a day hospital.",[92,93],"Chronic Heart Failure","Preserved Ejection Fraction","2023-06-02",{"date":96,"type":97},"2023-06-05","ACTUAL",{"date":99,"type":97},"2022-08-10",{"date":101,"type":86},"2029-06-10",{"name":5,"class":6},1]